NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/02/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
ST13
US500000097880973Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Primeiro uso
Primeiro uso no comércio
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of the stylized word "PENTEC"; under the word "PENTEC" in smaller stylized font is the word "HEALTH"; to the left of the stylized words "PENTEC" and "HEALTH" are four crescent shapes forming a swirl design around a small solid circle.
Titulares
Representantes
David P. Fitzgibbon STRADLEY RONON STEVENS & YOUNG, LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Oral nutritional supplements; dietetic foods adapted for medical use; parenteral nutrition delivered intravenously to treat patients with clinical nutritional deficiencies; enteral nutrition formulas used to treat individuals with inborn errors of metabolism and metabolic conditions; vials containing compounded sterile preparations in the nature of sterile pharmaceutical preparations for renal patients, wound care patients, pain and spasticity patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients; syringes containing compounded sterile preparations in the nature of sterile pharmaceutical preparations for renal patients, wound care patients, pain and spasticity patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients
Classe 35
Pharmaceutical services, namely, processing prescription drug orders in closed-door, sterile, compounding pharmacies; specialized closed-door, sterile, compounding pharmacy services, namely, processing prescription drug orders for renal patients, wound care patients, pain and spasticity patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients; consulting services, namely, providing consumer information about health care plans
Classe 36
Providing information regarding health care claim insurance, claim information, and payment options to health care providers, insurers, and consumers
Classe 41
Educational services, namely, providing educational seminars to industry healthcare professionals in the field of care of patients suffering from chronic kidney disease (CKD), end stage renal disease (ESRD), diabetes, intractable pain, and spasticity conditions, gastrointestinal disorders, clinical nutrition deficiencies related to chronic diseases, and cancer
Classe 44
Pharmaceutical advice for renal clinics, pain and spasticity management physician practices, nephrologists, dietitians, and oncologists; specialized closed-door, sterile, compounding pharmacy services, namely, pharmaceutical compounding services for renal patients, wound care patients, pain and spasticity patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients; healthcare, namely, providing specialty infusion therapy for renal patients, wound care patients, patients with implanted intrathecal pumps, patients with implanted hepatic artery pumps, pain and spasticity patients, patients with diabetes, patients with clinical nutrition deficiencies, and cancer patients; providing healthcare services featuring supplemental oral nutrition therapy, nutrition therapy, nutrition counseling, and medical food therapy programs to patients and healthcare providers; Health care services for treating patients with clinical nutrition deficiencies by providing medical food formulated for administration under medical supervision
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/02/2026
REGISTERED-PRINCIPAL REGISTER
17/02/2026
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
28/01/2026
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
28/01/2026
STATEMENT OF USE PROCESSING COMPLETE
08/01/2026
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/01/2026
USE AMENDMENT FILED
03/07/2025
TEAS STATEMENT OF USE RECEIVED
03/07/2025
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/03/2025
SOU EXTENSION 1 GRANTED
07/01/2025
SOU EXTENSION 1 FILED
07/01/2025
SOU TEAS EXTENSION RECEIVED
07/01/2025
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/01/2025
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/01/2025
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/01/2025
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/01/2025
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/07/2024
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/05/2024
PUBLISHED FOR OPPOSITION
14/05/2024
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/04/2024
APPROVED FOR PUB - PRINCIPAL REGISTER
09/04/2024
EXAMINER'S AMENDMENT ENTERED
09/04/2024
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/04/2024
EXAMINERS AMENDMENT E-MAILED
09/04/2024
EXAMINERS AMENDMENT -WRITTEN
09/04/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
06/04/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/04/2024
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/04/2024
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/01/2024
NON-FINAL ACTION E-MAILED
05/01/2024
NON-FINAL ACTION WRITTEN
05/01/2024
ASSIGNED TO EXAMINER
05/01/2024
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/05/2023
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/05/2023
NEW APPLICATION ENTERED
13/04/2023
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.